{"schema_version":"secwatch.filing_event.v1","accession":"0001641489-23-000082","form_type":"8-K","ticker":"VTVT","cik":"0001641489","company_name":"vTv Therapeutics Inc.","filed_at":"2023-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.912047+00:00","generated_at":"2026-06-07T14:14:48.500483+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"vTv Therapeutics regains Nasdaq minimum bid compliance after reverse stock split","bullets":["Nasdaq notified vTv on Dec 11, 2023 that it regained $1.00 minimum bid price compliance.","Company had received deficiency letter on Dec 22, 2022; extended deadline to Dec 18, 2023.","Effected a reverse stock split on Nov 20, 2023 to meet the bid price requirement.","Listing of common stock on Nasdaq Capital Market will continue."],"urls":{"canonical":"https://secwatch.observer/filing/0001641489-23-000082","json":"https://secwatch.observer/filing/0001641489-23-000082.json","markdown":"https://secwatch.observer/filing/0001641489-23-000082.md","text":"https://secwatch.observer/filing/0001641489-23-000082.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641489/000164148923000082/0001641489-23-000082-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641489/000164148923000082/vtvt-20231211.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T14:14:48.500483+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}